Gilead CEO says remdesivir will be available to treat coronavirus patients as early as this week
Dan O’Day, CEO of Gilead Sciences, said on Monday that the company had donated its entire supply of remdesivir to the US government to dish out to hospitals across the country The CEO of Gilead Sciences, the company that makes the promising drug remdesivir, says it will be available to treat COVID-19 patients as early … Read more